From: Breast involvement of hematological malignancies: imaging and clinical findings
Case | Age | Pathologic type | Primary/secondary lymphoma | Size (mm) | Sidea | Axillary LAP/skin thickening | MMG | US | MRI |
---|---|---|---|---|---|---|---|---|---|
1 | 83 | Diffuse large B-cell lymphoma | Primary | 36 | Lefta | +/+ | NA |
Irregular/non-circumscribed Hypoechoic Posterior enhancement Vascularity: NA | NA |
2 | 57 | Diffuse large B-cell lymphoma | Primary | 11 | Right | +/+ |
Oval-round Circumscribed Isodense |
Oval-round/non-circumscribed Hypoechoic Posterior enhancement Hypervascularity | NA |
3 | 37 | Diffuse large B-cell lymphoma | Secondary | 13 | Bilateral | +/+ |
Asymmetric density Isodense |
Irregular/non-circumscribed Hypoechoic Posterior phenomena: − Vascularity: NA | NA |
4 | 47 | Diffuse large B-cell lymphoma | Secondary | 160 | Left | +/+ | NA |
Irregular/non-circumscribed Heterogeneous Posterior phenomena: − Vascularity: NA | NA |
5 | 57 | Diffuse large B-cell lymphoma | Secondary | 47 | Righta | +/− |
Asymmetric density Hyperdense |
Oval-round/non-circumscribed Heterogeneous c Posterior enhancement Vascularity: NA |
Dynamic curve, 2 Diffusion restriction (ADC 0.542 × 10−3) T2-hyperintense |
6 | 67 | Diffuse large B-cell lymphoma | Primary | 81 | Righta | −/+ | NA |
Oval-round/circumscribed Heterogeneous c Posterior enhancement Vascularity: NA | NA |
7 | 65 | Diffuse large B-cell lymphoma | Secondary | 22 | Bilateral | +/+ |
Oval-round Circumscribed Hyperdense |
Oval-round/circumscribed Hypoechoic Posterior phenomena: − Hypervascularity | NA |
8 | 62 | Marginal zone lymphoma | Secondary | 30 | Lefta | −/− |
Oval-round Circumscribed Isodense |
Oval-round/circumscribed Heterogeneous c Posterior enhancement Hypervascularity | NA |
9 | 69 | Marginal zone lymphoma | Secondary | 14 | Bilateral | +/− |
Oval-round Circumscribed Hyperdense |
Oval-round/circumscribed Hypoechoic Posterior enhancement Hypervascularity | NA |
10 | 77 | Marginal zone lymphoma | Secondary | 54 | Lefta | +/− | NA |
Irregular/non-circumscribed Heterogeneous Posterior enhancement Vascularity: NA | NA |
11 | 48 | Marginal zone lymphoma | Primary | 13 | Righta | +/+ | NA |
Irregular/non-circumscribed Hypoechoic Posterior enhancement Hypervascularity | NA |
12 | 55 | Marginal zone lymphoma | Secondary | 32 | Left | +/− |
Irregular Non-circumscribed Hyperdense |
Irregular/non-circumscribed Hypoechoic Posterior enhancement Vascularity: NA |
Dynamic curve, 2 Diffusion restriction (ADC 0.558 × 10−3) T2-hyperintense |
13 | 19 | Granulocytic sarcoma | Primary | 35 | Left | −/− | NA |
Oval-round/circumscribed Heterogeneous c Posterior enhancement Hypervascularity | NA |
14 | 50 | Granulocytic sarcoma | Secondary | 25 | Left | −/+ | NA |
Irregular/non-circumscribed Heterogeneous c Posterior enhancement Vascularity: NA | NA |
15d | 22 | Granulocytic sarcoma | Secondary | 47 | Bilateral | +/+ b |
Oval-round Circumscribed Hyperdense |
Oval-round Circumscribed Heterogeneous c Posterior enhancement Vascularity: NA |
Dynamiccurve, 3 Diffusion restriction (ADC 0.403 × 10−3) T2-hyperintense |
16 | 21 | Hodgkin lymphoma | Secondary | 40 | Bilateral | +/+ | NA |
Irregular/non-circumscribed Heterogeneous c Posterior phenomena: − Vascularity: NA | NA |
17 | 36 | Hodgkin lymphoma | Secondary | 60 | Right | −/+ |
Irregular Non-circumscribed Hyperdense |
Irregular/non-circumscribed Heterogeneous Posterior enhancement Hypervascularity | NA |
18 | 22 | Precursor B lymphoblastic lymphoma | Secondary | 42 | Righta | −/− | NA |
Irregular/non-circumscribed Heterogeneous Posterior enhancement Hypervascularity | NA |
19 | 36 | Mycosis fungoides | Secondary | 46 | Righta | +/+b | NA |
Irregular/non-circumscribed Heterogeneous Posterior phenomena: − Hypervascularity | NA |
20 | 58 | Plasmacytoma | Secondary | 9 | Righta | +/− |
Oval-round Circumscribed Hyperdense |
Oval-round/Circumscribed Hypoechoic Vertical orientation Posterior phenomena: − Hypervascularity |
Dynamic curve, 2 Diffusion restriction (ADC 0.840 × 10−3) T2-hyperintense |